https://www.healio.com/news/optometry/20220802/aldeyra-reports-reproxalap-improves-dry-eye-disease-signs-symptoms
0
0
8/8/22 at 2:07pm
Organization
Healio
Authors
Reproxalap 0.25% ophthalmic solution achieved primary and secondary endpoints in a trial investigating treatment of dry eye disease, Aldeyra Therapeutics announced in a press release.In a double-masked, sequence-randomized, vehicle-controlled crossover clinic…
Create an account
or login to join the discussion